FDA Mulling Restrictions on Tylenol, Other Acetaminophen Products
The Food and Drug Administration is meeting beginning today to discuss possible ways to reduce overdoses of acetaminophen, the pain-killing drug found in popular brands such as Tylenol, Excedrin, Theraflu, and NyQuil.
Seven Years is Enough Monopoly Protection for Biotech Drugs, White House Says
The makers of brand-name biotechnology drugs should be shielded from competition from cheaper generic versions of the drugs for seven years but no longer, White House officials say.
New Novartis ‘Niche Drug’ Approved for Rare Genetic Disorder
Drug maker Novartis AG has gained Food and Drug Administration approval for a new drug that treats a rare genetic disorder which afflicts just a few thousand people in the world.
LexisNexis® Legal News Podcast for July 2, 2009
The EPA grants California’s greenhouse gas waiver request, and, the 5th Circuit affirms dismissal of claims against the U.S. arising from Hurricane Katrina. Hear these and other stories from LexisNexis® Mealey’s™ Intellectual Property, Emerging Drugs Devices, Pollution Liability and Mortgage Lending Reports. Copyright© 2009 LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, visit www.lexisnexis.com/mealeys.
LexisNexis® Legal News Podcast for July 1, 2009
There is a $1.67 billion verdict in a drug patent case, and, there are two California Supreme Court rulings involving that state’s unfair competition law. Hear these and other stories from LexisNexis® Mealey’s™ Intellectual Property, Cybertech and California Section 17200 Reports. Copyright© 2009 LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, visit www.lexisnexis.com/mealeys.
LexisNexis® Legal News Podcast for June 30, 2009
The U.S. Supreme Court says New Haven, Conn.’s failure to promote white firefighters violated Title VII of the Civil Rights Act, and, the high court finds New York’s Attorney General may bring enforcement actions against lenders. Hear these and other stories from LexisNexis® Mealey’s™ Employment Law, Lead Litigation, Financial Services Litigation and Mortgage Lending Reports. Copyright© 2009 LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, visit www.lexisnexis.com/mealeys.
